Target intelligence / Profile preview

Autophagy-lysosome machinery (null)

Target
null
Molecular classification
Other (organelle system/protein machinery)
01

Overview

The autophagy-lysosome machinery refers to the coordinated network of proteins, molecular complexes, and organelles responsible for intracellular degradation and recycling of cellular components through autophagy. This process involves the formation of autophagosomes, which encapsulate cytoplasmic material and then fuse with lysosomes for degradation. The lysosomal compartment contains hydrolytic enzymes that break down proteins, lipids, and organelles, enabling cellular adaptation to stress, maintenance of homeostasis, and removal of damaged or harmful material. Dysregulation of this system is implicated in various diseases, including neurodegeneration, cancer, and immune disorders[1][2][3][5][7].

Other names
Autophagy-lysosomal pathwayALPAutophagy-related pathwayLysosomal degradation machineryAutophagy machinery
02

Mechanism of action

Inhibition of lysosomal acidification (e.g., chloroquine, bafilomycin A1); Induction of autophagy (e.g., rapamycin via mTOR inhibition); Modulation of autophagosome-lysosome fusion; Inhibition of autophagy by blocking autophagosome maturation

03

Biological functions

Cellular homeostasisProtein and organelle quality controlDegradation and recycling of cytoplasmic contentsCellular adaptation to nutrient stressCell survivalRegulation of cell death
04

Disease associations

Neurodegenerative diseaseCancerInflammation/autoimmunityInfectious diseaseMetabolic disease
05

Safety considerations

Toxicity due to excessive autophagy inhibition or activation (e.g., tissue/cellular damage)Risk of immune suppression (autophagy inducers)Retinopathy and cardiotoxicity (with chloroquine/hydroxychloroquine due to lysosome inhibition)
06

Interacting drugs

Chloroquine (lysosome inhibitor)

5 more in the full profile.

07

Biomarkers

LC3-II (autophagosome marker)p62/SQSTM1 (substrate of autophagy)LAMP1/2 (lysosomal markers)Beclin 1

Beyond the preview

Go deeper on Autophagy-lysosome machinery (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy-lysosome machinery (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call